Rosana N. Chehin

San Miguel De Tucuman, T, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Expanding the DAD9-Pegasus Scaffold: Synthesis and Functional Evaluation of Sulfur-Containing Dopamine-Tetracycline Conjugates for Parkinson's Disease.

Expanding the DAD9-Pegasus Scaffold: Synthesis and Functional Evaluation of Sulfur-Containing Dopamine-Tetracycline Conjugates for Parkinson's Disease.

Journal: ChemMedChem

Published: April 30, 2026

Structure-Based Selection of a Tetracycline Derivative for Advanced Biosensor Platforms Targeting Aggregated α-Synuclein in Parkinson's Disease.

Structure-Based Selection of a Tetracycline Derivative for Advanced Biosensor Platforms Targeting Aggregated α-Synuclein in Parkinson's Disease.

Journal: ACS chemical neuroscience

Published: January 30, 2026

Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative.

Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative.

Journal: Biomolecules

Published: May 17, 2025

DDOX expands the repertoire of tetracyclines for Parkinson's disease by preventing the cellular uptake and intracellular impact of α-synuclein preformed fibrils.

DDOX expands the repertoire of tetracyclines for Parkinson's disease by preventing the cellular uptake and intracellular impact of α-synuclein preformed fibrils.

Journal: Scientific reports

Published: January 23, 2025

Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin.

Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin.

Journal: Neuropathology and applied neurobiology

Published: September 18, 2024

Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson's Disease.

Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson's Disease.

Journal: ACS chemical neuroscience

Published: July 11, 2024

Humoral Immune Response to SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases.

Humoral Immune Response to SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases.

Journal: Archives of medical research

Published: April 17, 2024

Impairment of Listeria monocytogenes biofilm developed on industrial surfaces by Latilactobacillus curvatus CRL1579 bacteriocin.

Impairment of Listeria monocytogenes biofilm developed on industrial surfaces by Latilactobacillus curvatus CRL1579 bacteriocin.

Journal: Food microbiology

Published: January 08, 2024

C9-Functionalized Doxycycline Analogs as Drug Candidates to Prevent Pathological α-Synuclein Aggregation and Neuroinflammation in Parkinson's Disease Degeneration.

C9-Functionalized Doxycycline Analogs as Drug Candidates to Prevent Pathological α-Synuclein Aggregation and Neuroinflammation in Parkinson's Disease Degeneration.

Journal: ChemMedChem

Published: October 31, 2023

Magnetic amyloid-based biocatalyst for the hydrolysis of urea.

Magnetic amyloid-based biocatalyst for the hydrolysis of urea.

Journal: Food chemistry

Published: March 08, 2023

Rescue of Dopamine Neurons from Iron-Dependent Ferroptosis by Doxycycline and Demeclocycline and Their Non-Antibiotic Derivatives.

Rescue of Dopamine Neurons from Iron-Dependent Ferroptosis by Doxycycline and Demeclocycline and Their Non-Antibiotic Derivatives.

Journal: Antioxidants (Basel, Switzerland)

Published: January 22, 2023

Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound.

Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound.

Journal: Cells

Published: July 28, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026